Pontine Tumors Recruiting Phase 2 Trials for Dasatinib (DB01254)

IndicationStatusPhase
DBCOND0045990 (Pontine Tumors)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03352427Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring PDGFR AlterationsTreatment